跳至主要内容
临床试验/CTRI/2020/08/027160
CTRI/2020/08/027160尚未招募未知

A double blinded, randomized, controlled, monocentric study toevaluate and compare the immediate anti-dandruff efficacy of the test shampoo (Dabur Vatika Germ Protection Shampoo -BNo.02/150)

Dabur India Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male or female subjects in general good health.
  • 2. Subjects in the age group 18-50 years (both the ages inclusive).
  • 3. Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
  • 4. Subjects with moderate dandruff score of >20 or above of adherent and non adherent dandruff on each lateral side (total dandruff severity scale) and with visible flakes
  • 5. Subjects willing to abide by and comply with the study protocol.
  • 6. Subjects who agree to refrain from using any hair product (including shampoo and hair oil) for 48 hours post hair wash

排除标准

  • 1. Subjects having any active scalp disease which may interfere in the studyâ??dermatologistâ??s judgement.
  • 2. Female subjects who are known to be pregnant
  • 3. Subjects with frizzy hair that may influence in the scoring of dandruff
  • 4. Subjects with significant white hair influencing the scoring of dandruff
  • 5. Subjects who have had hair transplant.
  • 6. Subjects who have taken any systemic drug containing corticoids, or anti-fungal, or antibiotics, or any prolonged use of topical drug containing Corticosteroid, or anti-fungal,
  • or antibiotics, or any prolonged use of non-steroidal anti-inflammatory, or
  • anti-histaminic within 2 weeks prior to the study;
  • 7. Any history of underlying uncontrolled medical illness including diabetes mellitus,
  • hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness

研究者

相似试验

To evaluate the efficacy of anti-dandruff shampoo... | 临床试验